Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study.
Aquilani R, Brugnatelli S, Dossena M, Maestri R, Delfanti S, Buonocore D, Boschi F, Simeti E, Condino AM, Verri M. Aquilani R, et al. Among authors: delfanti s. Nutrients. 2019 Nov 5;11(11):2667. doi: 10.3390/nu11112667. Nutrients. 2019. PMID: 31694176 Free PMC article.
Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.
Manzoni M, Mariucci S, Delfanti S, Rovati B, Ronzoni M, Loupakis F, Brugnatelli S, Tinelli C, Villa E, Falcone A, Danova M. Manzoni M, et al. Among authors: delfanti s. J Cancer Res Clin Oncol. 2012 Jul;138(7):1187-96. doi: 10.1007/s00432-012-1190-6. Epub 2012 Mar 15. J Cancer Res Clin Oncol. 2012. PMID: 22419441
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).
Pedrazzoli P, Silvestris N, Santoro A, Secondino S, Brunetti O, Longo V, Mancini E, Mariucci S, Rampino T, Delfanti S, Brugnatelli S, Cinieri S. Pedrazzoli P, et al. Among authors: delfanti s. ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017. ESMO Open. 2017. PMID: 29209521 Free PMC article.
In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation Status.
Turin I, Delfanti S, Ferulli F, Brugnatelli S, Tanzi M, Maestri M, Cobianchi L, Lisini D, Luinetti O, Paulli M, Perotti C, Todisco E, Pedrazzoli P, Montagna D. Turin I, et al. Among authors: delfanti s. J Immunother. 2018 May;41(4):190-200. doi: 10.1097/CJI.0000000000000205. J Immunother. 2018. PMID: 29293164
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer.
Rosati G, Addeo R, Aprile G, Avallone A, Bilancia D, Brugnatelli S, Buccafusca G, Carlomagno C, Cordio S, Delfanti S, Dell'Aquila E, Di Bisceglie M, Di Donato S, Di Stasi A, Germano D, Giuliani F, Granetto C, Latiano TP, Leo S, Tralongo P, Stroppolo ME, Venturini F, Bianco S. Rosati G, et al. Among authors: delfanti s. Cancer Chemother Pharmacol. 2019 Nov;84(5):1089-1096. doi: 10.1007/s00280-019-03943-x. Epub 2019 Sep 6. Cancer Chemother Pharmacol. 2019. PMID: 31493178
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study.
Vitolo V, Cobianchi L, Brugnatelli S, Barcellini A, Peloso A, Facoetti A, Vanoli A, Delfanti S, Preda L, Molinelli S, Klersy C, Fossati P, Orecchia R, Valvo F. Vitolo V, et al. Among authors: delfanti s. BMC Cancer. 2019 Sep 14;19(1):922. doi: 10.1186/s12885-019-6108-0. BMC Cancer. 2019. PMID: 31521134 Free PMC article. Clinical Trial.
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial.
Caccialanza R, Cereda E, Klersy C, Brugnatelli S, Borioli V, Ferrari A, Caraccia M, Lobascio F, Pagani A, Delfanti S, Aprile G, Reni M, Rimassa L, Melisi D, Cascinu S, Battistini L, Candiloro F, Pedrazzoli P. Caccialanza R, et al. Among authors: delfanti s. Ther Adv Med Oncol. 2020 Feb 22;12:1758835919890281. doi: 10.1177/1758835919890281. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32127922 Free PMC article.
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial.
Cremolini C, Marmorino F, Bergamo F, Aprile G, Salvatore L, Masi G, Dell'Aquila E, Antoniotti C, Murgioni S, Allegrini G, Borelli B, Gemma D, Casagrande M, Granetto C, Delfanti S, Di Donato S, Schirripa M, Sensi E, Tonini G, Lonardi S, Fontanini G, Boni L, Falcone A. Cremolini C, et al. Among authors: delfanti s. Eur J Cancer. 2019 Mar;109:175-182. doi: 10.1016/j.ejca.2018.12.028. Epub 2019 Feb 5. Eur J Cancer. 2019. PMID: 30735919 Clinical Trial.
34 results